BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/14/2025 10:52:07 AM | Browse: 6 | Download: 26
Publication Name World Journal of Diabetes
Manuscript ID 108101
Country China
Received
2025-04-07 09:40
Peer-Review Started
2025-04-16 09:01
To Make the First Decision
Return for Revision
2025-04-24 02:46
Revised
2025-05-08 15:16
Second Decision
2025-06-17 02:48
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-07-02 09:11
Articles in Press
2025-07-02 09:11
Publication Fee Transferred
2025-05-10 16:23
Edit the Manuscript by Language Editor
2025-07-17 21:04
Typeset the Manuscript
2025-08-04 02:59
Publish the Manuscript Online
2025-08-14 10:52
ISSN 1948-9358 (online)
Open Access Diabetic cystopathy (DCP), a debilitating complication of diabetes mellitus, involves hyperglycemia-driven bladder dysfunction. This study identified CREB3 L3 as a novel mediator of DCP pathogenesis. Chronic hyperglycemia induced CREB3 L3 overexpression in bladder urothelium, promoting C-reactive protein-dependent inflammation, epithelial-mesenchymal transition (EMT) and tight junction disruption. Silencing CREB3 L3 in SV-HUC-1 urothelial cells and a DCP rat model reversed EMT markers (downregulation of N-cadherin and upregulation of E-cadherin protein), restored barrier proteins (Occludin/Claudin1 protein), and attenuated bladder remodeling. These findings have established CREB3 L3 as a therapeutic target to preserve urothelial integrity and mitigate DCP progression.
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Urology & Nephrology
Manuscript Type Basic Study
Article Title Hyperglycemia-induced overexpression of CREB3 L3 promotes the epithelial-to-mesenchymal transition in bladder urothelial cells in diabetes mellitus
Manuscript Source Unsolicited Manuscript
All Author List Qing-Guo Wu, Ming-Jin Zhang, Yi-Bi Lan, Chun-Lei Ma and Wei-Jin Fu
ORCID
Author(s) ORCID Number
Wei-Jin Fu http://orcid.org/0009-0004-1387-7159
Funding Agency and Grant Number
Funding Agency Grant Number
GuangXi Natural Science Foundation 2024GXNSFAA010031
Corresponding Author Wei-Jin Fu, Chief Physician, Department of Urology, The First Affiliated Hospital of GuangXi Medical University, No. 6 Shuangyong Road, Qinxiu District, Nanning 530022, Guangxi Zhuang Autonomous Region, China. fwjgxmu1978@163.com
Key Words Hyperglycemia; Epithelial-mesenchymal transition; Diabetic cystopathy
Core Tip Diabetic cystopathy (DCP), a debilitating complication of diabetes mellitus, involves hyperglycemia-driven bladder dysfunction. This study identified CREB3 L3 as a novel mediator of DCP pathogenesis. Chronic hyperglycemia induced CREB3 L3 overexpression in bladder urothelium, promoting C-reactive protein-dependent inflammation, epithelial-mesenchymal transition (EMT) and tight junction disruption. Silencing CREB3 L3 in SV-HUC-1 urothelial cells and a DCP rat model reversed EMT markers (downregulation of N-cadherin and upregulation of E-cadherin protein), restored barrier proteins (Occludin/Claudin1 protein), and attenuated bladder remodeling. These findings have established CREB3 L3 as a therapeutic target to preserve urothelial integrity and mitigate DCP progression.
Publish Date 2025-08-14 10:52
Citation <p>Wu QG, Zhang MJ, Lan YB, Ma CL, Fu WJ. Hyperglycemia-induced overexpression of CREB3 L3 promotes the epithelial-to-mesenchymal transition in bladder urothelial cells in diabetes mellitus. <i>World J Diabetes</i> 2025; 16(8): 108101</p>
URL https://www.wjgnet.com/1948-9358/full/v16/i8/108101.htm
DOI https://dx.doi.org/10.4239/wjd.v16.i8.108101
Full Article (PDF) WJD-16-108101-with-cover.pdf
The ARRIVE Guidelines 108101-The-ARRIVE-Guidelines.pdf
Manuscript File 108101_Auto_Edited_075349.docx
Answering Reviewers 108101-answering-reviewers.pdf
Audio Core Tip 108101-audio.mp3
Biostatistics Review Certificate 108101-biostatistics-statement.pdf
Conflict-of-Interest Disclosure Form 108101-conflict-of-interest-statement.pdf
Copyright License Agreement 108101-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 108101-foundation-statement.pdf
Institutional Animal Care and Use Committee Approval Form or Document 108101-institutional-animal-care-and-use-committee-statement.pdf
Institutional Review Board Approval Form or Document 108101-institutional-review-board-statement.pdf
Non-Native Speakers of English Editing Certificate 108101-non-native-speakers.pdf
Peer-review Report 108101-peer-reviews.pdf
Scientific Editor Work List 108101-scientific-editor-work-list.pdf
CrossCheck Report 108101-crosscheck-report.pdf